Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib and Docetaxel in Metastatic Prostate Cancer
NCT00619996Phase 2Completed
- Start
- Mar 2007
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in prostate cancer (PCa). Started Mar 2007; status: completed.
02
Drugs
sorafenib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00619996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00619996.